11
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Formulation and characterization of azidothymidine-loaded liposomes

&
Pages 223-229 | Received 16 Oct 1995, Accepted 01 May 1996, Published online: 27 Sep 2008
 

Abstract

Entrapment efficiency (EE%) and in vitro stability of azidothymidine (AZT)-loaded hand-shaken multilamellar vesicles (MLVs), freeze and thaw vesicles (FATMLVs), and reverse phase evaporation vesicles (REVs) were compared. AZT entrapment in FATMLVs was further studied by varying initial lipid concentrations, drug concentration, and lipid composition. The results suggest that AZT entrapment is dependent on the aqueous volume entrapped within liposomes, and the interaction between the drug and liposomal bilayer may not be significant. Increasing the lipid concentration increases the liposomal entrapment of AZT but the encapsulation yield decreases above a lipid concentration of 30 μmol/mL. No significant difference was observed in EE% when the AZT concentration was varied from 5 to 20 mg/mL. The entrapment efficiency was highest (43.2%) for DSPC/CHOL/PS (molar ratio 6:3:3) vesicles but DSPC/CHOL/PS liposome formulations in a molar ratio of 4:3:3 or 4:5:1 and DSPC/CHOL/SA liposome formulations in a molar ratio of 4:5:1 were found to be more stable in vitro. In vitro drug release from liposomes was dependent on bilayer composition and the method of preparation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.